Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Erkan, Mert ^a   Weis, Nadine ^b   Pan, Zheng ^a   Schwager, Christian ^b   Samkharadze, Tamar ^a   Jiang, Xiaohua ^a   Wirkner, Ute ^b   Giese, Nathalia A ^c   Ansorge, Wilhelm ^b   Debus, Jürgen ^b   Huber, Peter E ^b   Friess, Helmut ^a   Abdollahi, Amir ^b,d,e   Kleeff, Jörg ^a,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN EGF LAG SEVEN PASS G TYPE RECEPTOR 3; COLLAGEN TYPE 11; COLLAGEN TYPE 11A1; JANUS KINASE 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR PBX1; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; TUMOR MARKER;

ARTICLE; CELL ISOLATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER METASTASIS; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; TISSUE SPECIFICITY; UPREGULATION; GENETICS; INFLAMMATION; LIVER TUMOR; METASTASIS; PANCREAS TUMOR; PATHOLOGY;

CARCINOMA, PANCREATIC DUCTAL; DNA FINGERPRINTING; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HEPATIC STELLATE CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77951145570     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-88     Document Type: Article

References (51)

1. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008, 88:125-172. 10.1152/physrev.00013.2007, 18195085.
2. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669. 10.1053/j.gastro.2008.03.003, 18471545.
3. Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007, 117:50-59. 10.1172/JCI30082, 1716214, 17200706.
4. Erkan M, Reiser-Erkan C, Michalski CW, Deucker S, Sauliunaite D, Streit S, Esposito I, Friess H, Kleeff J. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia 2009, 11:497-508. 2671860, 19412434.
5. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461. 10.1126/science.1171362, 19460966.
6. Watari N, Hotta Y, Mabuchi Y. Morphological studies on a vitamin A-storing cell and its complex with macrophage observed in mouse pancreatic tissues following excess vitamin A administration. Okajimas Folia Anat Jpn 1982, 58:837-858.
7. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998, 43:128-133. 1727174, 9771417.
8. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432. 10.1016/S0016-5085(98)70209-4, 9679048.
9. Buchholz M, Kestler HA, Holzmann K, Ellenrieder V, Schneiderhan W, Siech M, Adler G, Bachem MG, Gress TM. Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype. J Mol Med 2005, 83:795-805. 10.1007/s00109-005-0680-2, 15976918.
10. Asahina K, Tsai SY, Li P, Ishii M, Maxson RE, Sucov HM, Tsukamoto H. Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology 2008,
11. Enzan H, Himeno H, Hiroi M, Kiyoku H, Saibara T, Onishi S. Development of hepatic sinusoidal structure with special reference to the Ito cells. Microsc Res Tech 1997, 39:336-349. 10.1002/(SICI)1097-0029(19971115)39:4<336::AID-JEMT4>3.0.CO;2-F, 9407544.
12. Kiassov AP, Van Eyken P, van Pelt JF, Depla E, Fevery J, Desmet VJ, Yap SH. Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study. Differentiation 1995, 59:253-258. 10.1046/j.1432-0436.1995.5940253.x, 8575647.
13. Vassy J, Rigaut JP, Briane D, Kraemer M. Confocal microscopy immunofluorescence localization of desmin and other intermediate filament proteins in fetal rat livers. Hepatology 1993, 17:293-300. 10.1002/hep.1840170221, 7679087.
14. Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 2002, 37:527-535. 10.1016/S0168-8278(02)00263-5, 12217608.
15. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000, 275:2247-2250. 10.1074/jbc.275.4.2247, 10644669.
16. Niki T, Pekny M, Hellemans K, Bleser PD, Berg KV, Vaeyens F, Quartier E, Schuit F, Geerts A. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology 1999, 29:520-527. 10.1002/hep.510290232, 9918930.
17. Geerts A. On the origin of stellate cells: mesodermal, endodermal or neuro-ectodermal?. J Hepatol 2004, 40:331-334. 10.1016/j.jhep.2003.12.006, 14739107.
18. Erkan M, Michalski CW, Rieder S, Reiser-Erkan C, Abiatari I, Kolb A, Giese NA, Esposito I, Friess H, Kleeff J. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 2008, 6:1155-1161. 10.1016/j.cgh.2008.05.006, 18639493.
19. Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid-Kotsas A, Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005, 128:907-921. 10.1053/j.gastro.2004.12.036, 15825074.
20. Vonlaufen A, Xu Z, Daniel B, Kumar RK, Pirola R, Wilson J, Apte MV. Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model. Gastroenterology 2007, 133:1293-1303. 10.1053/j.gastro.2007.06.062, 17919500.
21. Abdollahi A, Hlatky L, Huber PE. Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat 2005, 8:59-74. 10.1016/j.drup.2005.03.001, 15939343.
22. Michalski CW, Erkan M, Sauliunaite D, Giese T, Stratmann R, Sartori C, Giese NA, Friess H, Kleeff J. Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. Br J Cancer 2008, 99:760-767. 10.1038/sj.bjc.6604528, 2528151, 18728667.
23. Domhan S, Zeier M, Abdollahi A. Immunosuppressive therapy and post-transplant malignancy. Nephrol Dial Transplant 2008,
24. Abdollahi A, Schwager C, Kleeff J, Esposito I, Domhan S, Peschke P, Hauser K, Hahnfeldt P, Hlatky L, Debus J, et al. Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci USA 2007, 104:12890-12895. 10.1073/pnas.0705505104, 1931565, 17652168.
25. Li J, Kleeff J, Kayed H, Felix K, Penzel R, Buchler MW, Korc M, Friess H. Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells. Biochem Biophys Res Commun 2004, 320:1148-1155. 10.1016/j.bbrc.2004.06.063, 15249209.
26. Domhan S, Muschal S, Schwager C, Morath C, Wirkner U, Ansorge W, Maercker C, Zeier M, Huber PE, Abdollahi A. Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Ther 2008, 7:1656-1668. 10.1158/1535-7163.MCT-08-0193, 18566237.
27. Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W, Folkman J, Hlatky L, Huber PE. Endostatin's antiangiogenic signaling network. Mol Cell 2004, 13:649-663. 10.1016/S1097-2765(04)00102-9, 15023336.
28. Erkan M, Kleeff J, Esposito I, Giese T, Ketterer K, Buchler MW, Giese NA, Friess H. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 2005, 24:4421-4432. 10.1038/sj.onc.1208642, 15856026.
29. Reiser-Erkan C, Erkan M, Pan Z, Bekasi S, Giese NA, Streit S, Michalski CW, Friess H, Kleeff J. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther 2008, 7:1352-1359.
30. Erkan M, Kleeff J, Gorbachevski A, Reiser C, Mitkus T, Esposito I, Giese T, Buchler MW, Giese NA, Friess H. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007, 132:1447-1464. 10.1053/j.gastro.2007.01.031, 17408641.
31. Kota J, Caceres N, Constantinescu SN. Aberrant signal transduction pathways in myeloproliferative neoplasms. Leukemia 2008, 22:1828-1840. 10.1038/leu.2008.236, 18769448.
32. McCubrey JA, Steelman LS, Abrams SL, Bertrand FE, Ludwig DE, Basecke J, Libra M, Stivala F, Milella M, Tafuri A, et al. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia 2008, 22:708-722. 10.1038/leu.2008.27, 18337766.
33. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep 2005, 14:1583-1588.
34. Wu Q, Maniatis T. Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. Proc Natl Acad Sci USA 2000, 97:3124-3129. 10.1073/pnas.060027397, 16203, 10716726.
35. Loeffler M, Kruger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 2006, 116:1955-1962. 10.1172/JCI26532, 1481657, 16794736.
36. Jaster R, Hilgendorf I, Fitzner B, Brock P, Sparmann G, Emmrich J, Liebe S. Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all-trans retinoic acid. Biochem Pharmacol 2003, 66:633-641. 10.1016/S0006-2952(03)00390-3, 12906928.
37. Pinzani M. Pancreatic stellate cells: new kids become mature. Gut 2006, 55:12-14. 10.1136/gut.2005.074427, 1856367, 16344573.
38. Gelse K, Poschl E, Aigner T. Collagens--structure, function, and biosynthesis. Adv Drug Deliv Rev 2003, 55:1531-1546. 10.1016/j.addr.2003.08.002, 14623400.
39. Iyama K, Sumiyoshi H, Khaleduzzaman M, Matsuo N, Ninomiya Y, Yoshioka H. Differential expression of two exons of the alpha1(XI) collagen gene (Col11a1) in the mouse embryo. Matrix Biol 2001, 20:53-61. 10.1016/S0945-053X(00)00130-X, 11246003.
40. Lui VC, Kong RY, Nicholls J, Cheung AN, Cheah KS. The mRNAs for the three chains of human collagen type XI are widely distributed but not necessarily co-expressed: implications for homotrimeric, heterotrimeric and heterotypic collagen molecules. Biochem J 1995, 311(Pt 2):511-516. 1136028, 7487888.
41. So CL, Kaluarachchi K, Tam PP, Cheah KS. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. Osteoarthritis Cartilage 2001, 9(Suppl A):S160-173.
42. Yoshioka H, Greenwel P, Inoguchi K, Truter S, Inagaki Y, Ninomiya Y, Ramirez F. Structural and functional analysis of the promoter of the human alpha 1(XI) collagen gene. J Biol Chem 1995, 270:418-424. 10.1074/jbc.270.1.418, 7814404.
43. Yoshioka H, Iyama K, Inoguchi K, Khaleduzzaman M, Ninomiya Y, Ramirez F. Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). Dev Dyn 1995, 204:41-47.
44. Annunen S, Korkko J, Czarny M, Warman ML, Brunner HG, Kaariainen H, Mulliken JB, Tranebjaerg L, Brooks DG, Cox GF, et al. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet 1999, 65:974-983. 10.1086/302585, 1288268, 10486316.
45. Griffith AJ, Sprunger LK, Sirko-Osadsa DA, Tiller GE, Meisler MH, Warman ML. Marshall syndrome associated with a splicing defect at the COL11A1 locus. Am J Hum Genet 1998, 62:816-823. 10.1086/301789, 1377029, 9529347.
46. Li Y, Lacerda DA, Warman ML, Beier DR, Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, Andrikopoulos K, Ramirez F, et al. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell 1995, 80:423-430. 10.1016/0092-8674(95)90492-1, 7859283.
47. Seegmiller R, Fraser FC, Sheldon H. A new chondrodystrophic mutant in mice. Electron microscopy of normal and abnormal chondrogenesis. J Cell Biol 1971, 48:580-593. 10.1083/jcb.48.3.580, 2108112, 4100752.
48. Michalski CW, Gorbachevski A, Erkan M, Reiser C, Deucker S, Bergmann F, Giese T, Weigand M, Giese NA, Friess H, Kleeff J. Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis. J Transl Med 2007, 5:63. 10.1186/1479-5876-5-63, 2234395, 18053242.
49. Michalski CW, Maier M, Erkan M, Sauliunaite D, Bergmann F, Pacher P, Batkai S, Giese NA, Giese T, Friess H, Kleeff J. Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells. PLoS ONE 2008, 3:e1701. 10.1371/journal.pone.0001701, 2253501, 18301776.
50. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 1999, 44:534-541. 10.1136/gut.44.4.534, 1727467, 10075961.
51. Bachem MG, Zhou Z, Zhou S, Siech M. Role of stellate cells in pancreatic fibrogenesis associated with acute and chronic pancreatitis. J Gastroenterol Hepatol 2006, 21(Suppl 3):S92-96. 10.1111/j.1440-1746.2006.04592.x, 16958683.